Abstract
The biodistribution of radiotracers used in diagnostic imaging is grossly and recognizably altered by a wide variety of drugs and other treatment modalities, such as surgery and radiotherapy. Knowledge of such altered biodistribution is important both in making diagnostic inferences from scans and in dosimetric considerations.
MeSH terms
-
Anesthetics
-
Contrast Media / metabolism
-
Drug Interactions*
-
Drug Therapy
-
Gallium Radioisotopes
-
Humans
-
Immunotherapy
-
Pulmonary Fibrosis / chemically induced
-
Pulmonary Fibrosis / metabolism
-
Radioisotopes / metabolism*
-
Radiotherapy
-
Renal Dialysis
-
Technetium / metabolism*
-
Tissue Distribution
Substances
-
Anesthetics
-
Contrast Media
-
Gallium Radioisotopes
-
Radioisotopes
-
Technetium